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Abstract: 
Background-This study investigated the usefulness of self-report scales for detecting bipolar 
disorder in several settings. 
Methods-Study 1 developed a short form of the Hypomanic Personality Scale (the HPS-6) based 
on clinic/community and undergraduate samples. Study 2 used this scale for recruiting 
participants with bipolar disorder from the community. Study 3 administered the full-length 
Hypomanic Personality Scale, the Mood Disorder Questionnaire, and a short form of the General 
Behavior Inventory (the GBI-15) to an undergraduate sample. Each study featured a reference 
standard diagnostic interview. 
Results-In Study 2, about half of those responding to the advertisement (based on the HPS-6 
developed in Study 1) reported a history of at least one hypomanic episode on a telephone-based 
SCID. In Study 3, the most robust findings emerged for the GBI-15: about one-third of 
participants screening positive on that measure met criteria for bipolar disorder using the 
Structured Clinical Interview for the DSM-IV (SCID). 
Limitations-Despite large sample sizes and stratified sampling, this study was limited by a low 
number of participants with bipolar I disorder. 
Conclusions-These three studies produced mixed findings regarding the detection of bipolar 
disorder via self-report. The HPS-6 was reasonably successful in recruiting participants with a 
history of at least one manic or hypomanic episode into a study on bipolar disorder. The GBI-15 
showed some promise as a screening tool in an undergraduate setting, but there is a need for 
more sensitive and specific scales. Discussion focuses on potential strategies for developing such 
scales. 
 
Article: 
INTRODUCTION 
Bipolar disorder is associated with high health care costs, lost productivity, elevated medical 
comorbidity, hospitalization, and the risk of suicide (Andlin-Sobocki and Wittchen, 2005, 
Baldessarini and Tondo, 2003, Kupfer, 2005 and Peele et al., 2003). The lifetime prevalence of 
bipolar I disorder is reported to be approximately 1% (Judd and Akiskal, 2003, Kessler et al., 
1997, Kessler et al., 2005, Kessler et al., 1994, Narrow et al., 2002, Regier et al., 
1993 and Weissman et al., 1996). For bipolar II disorder, some authors argue that estimates of 
1.1% (Merikangas et al., 2007) are artifactually low, due to poor sensitivity of diagnostic 
measures (Angst and Cassano, 2005). Estimates of the prevalence of cyclothymia range from 
0.4% (American Psychiatric Association, 2000) up to 4% (Regeer et al., 2004). 
 
Even though bipolar disorder affects many people, it is often misdiagnosed. Studies conducted in 
the United States and Europe indicate that 26 to 70% of people with bipolar disorder may either 
receive an incorrect diagnosis or go undiagnosed altogether. Proper diagnosis may not occur for 
a decade after bipolar symptoms emerge, especially for those with bipolar II disorder (Ghaemi et 
al., 2005, Lewis, 2004, Lish et al., 1994 and Mantere et al., 2004). A significant percentage of 
those presenting with unipolar depression may actually suffer from some type of bipolar disorder 
(Dunner, 2003). 
 
Several factors may contribute to this lack of recognition of the illness (Benazzi et al., 2004). 
Most people with bipolar disorder who seek treatment do so because of their depression rather 
than mania (Hirschfeld et al., 2005) and perceive their depression to be more troublesome than 
their mania (Calabrese et al., 2004). Some people with bipolar disorder lack insight into the 
presence or consequences of their manic symptoms. Hypomanic episodes, by definition, do not 
cause severe impairment or distress, so they are less likely to be defined as a problem by people 
who experience them. When people with bipolar disorder seek treatment for depression, their 
symptom profile may be virtually indistinguishable from that of unipolar depression (Cuellar et 
al., 2005). In addition, many clinicians do not screen for bipolar disorder, even when a client 
presents with depressive symptoms (Brickman et al., 2002). 
 
Unfortunately, the consequences of misdiagnoses are serious. Misdiagnosis as unipolar 
depression can lead to antidepressant monotherapy, which may trigger mania or rapid cycling in 
up to 50% of people with bipolar disorder (Ghaemi et al., 2004). 
 
One potential solution to the problem of misdiagnosis could be the use of brief self-report scales 
to alert providers to the possibility of bipolar disorder. This would allow clinicians to complete a 
more rigorous diagnostic assessment with patients who seem most likely to have a bipolar 
disorder. Several such scales have been developed, including the Hypomanic Personality Scale 
(HPS; Eckblad and Chapman, 1986), the Mood Disorder Questionnaire (MDQ; Hirschfeld et al., 
2000), the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego—Autoquestionnaire 
version (TEMPS-A; Akiskal et al., 2005), the Bipolar Spectrum Diagnostic Scale (BSDS; 
Ghaemi et al., 2005), the General Behavior Inventory (GBI; Depue et al., 1989), and the 
Hypomania Checklist (HCL; Angst et al., 2005). 
 
Each of these scales has strengths. For example, they generally have high internal consistency, 
and each yields significantly higher scores in patient populations than among healthy controls. 
Several of them have demonstrated at least modest sensitivity and specificity. For instance, the 
MDQ had a sensitivity of .73 and a specificity of .90 in one study (Hirschfeld et al., 2000). More 
than three quarters of a sample of students scoring high on the HPS had a history of at least one 
hypomanic episode; none with low scores had a hypomanic history (Eckblad and Chapman, 
1986). The GBI has shown a sensitivity of .78 and a specificity of greater than .98 in two studies 
(Depue et al., 1981 and Klein et al., 1989). The HCL (32-item version) has more limited 
specificity in detecting bipolar disorder (Angst et al., 2005); however, this may reflect its goal of 
detecting hypomania, which is less easily distinguished from normal functioning. The TEMPS-A 
has been studied extensively in Europe, and was the subject of an issue of the Journal of 
Affective Disorders (Akiskal et al., 2005); however, sensitivity and specificity estimates for this 
measure have not yet been published. 
 
Some measures are too long to be widely used as screeners. For example, although the GBI has 
been well-validated (Angst et al., 2005), its full 73-item version can take more than 20 min to 
complete. Shorter versions of the GBI have been developed (Lewinsohn et al., 2003 and Meyer 
and Hautzinger, 2003), but have not been validated in other samples. In sum, successful 
detection of bipolar disorder via self-report scales faces difficult challenges. First, it is not clear 
that existing scales have adequate sensitivity to bipolar disorder for use in routine screening. 
Second, the length of some scales (e.g., the GBI) limits their utility for screening. 
 
The studies reported here were designed to add to the literature on the detection of bipolar 
disorder by further testing measures that have shown promising sensitivity and specificity in 
previous research. Study 1 developed a brief version of the HPS and tested it across samples. The 
HPS was chosen because it has yet to be applied to clinical samples and may hold promise for 
detecting bipolar II disorder due to its attention to hypomanic traits. Study 2 used the small set of 
items derived from Study 1 in an advertising campaign to recruit research participants into a 
study on bipolar disorder. Study 3 involved administration of screening questionnaires (including 
the HPS-6 produced in Study 1 and tested in Study 2) to a large sample of undergraduates, 
yielding a sample enriched for vulnerability to bipolar disorder that was studied in detail. That 
study included the HPS due to its long-standing application to undergraduate populations, and 
the MDQ because it has been extensively studied in clinical settings. The only study to use the 
MDQ in an undergraduate population did not include a diagnostic interview to examine 
correspondence between the MDQ and bipolar diagnoses (Chandler et al., 2008). The complete 
GBI is too long to serve as a screening measure, but we included a shortened version, the GBI-15 
(Meyer and Johnson, 2003) based on the existing psychometric evidence for the 73-item version. 
 
STUDY 1 
The goal of Study 1 was to develop a briefer version of the HPS that could be used to reliably 
screen for bipolar disorder. The original HPS has 48 true–false items and takes about 7 min to 
complete. The goal was to create a subset of items that could be completed in less than 2 min, 
which would be appropriate for advertisements or posters. Such a set of items then could be used 
to recruit potentially bipolar participants for studies through notices in papers or public 
transportation.1 
 
Methods 
Methods for Study 1 were approved by the Institutional Review Boards at the University of 
Miami and the University of Wisconsin-Madison before data collection. 
 
Participants. This study included participants from two samples. One was an undergraduate 
sample, studied earlier by Eckblad and Chapman (1986). That sample consisted of 40 college 
students with z-scores of less than .50 on the HPS, and 40 students with z-scores above 1.67 (for 
women) or 1.82 (for men) on the HPS. The undergraduate sample was 50% female and had an 
average age of 19.41 years; total age range was from 16 to 24 years, and all of the participants 
were White non-Hispanic. The second sample was a clinic/community sample, and included 
participants from a large Day Hospital program for mood disorders (n = 90) as well as 
participants recruited through community advertising (n = 37). Participants from the Day 
Hospital had diagnoses of major depression or bipolar disorder, while participants from the 
community did not have any mood disorder diagnosis. This combined clinic/community sample 
was 62% female, 13% African-American, 27% Hispanic, 58% White non-Hispanic, and 3% of 
other or mixed race/ethnicity; age for this subsample was 39.55 ± 11.87 years with a total range 
of 20 to 65 years. 
 
Measures. As stated earlier, the study focused on the HPS. Bipolar diagnoses (including bipolar 
I or bipolar II disorder) based on the Schedule for Affective Disorders and Schizophrenia 
(SADS-L; Endicott and Spitzer, 1978) served as the reference standard for the undergraduate 
sample, while the Structured Clinical Interview for DSM-IV (First and Gibbon, 2004) served as 
the reference standard for the clinic/community sample. 
 
Hypomanic Personality Scale (HPS). The HPS (Eckblad and Chapman, 1986) is a 48-item 
measure designed to assess subsyndromal manic symptoms. Items are in a true/false format; 
sample items include “Sometimes ideas and insights come to me so fast that I cannot express 
them all” (keyed true) and “I am usually in an average sort of mood, not too high and not too 
low” (keyed false). The full 48-item HPS has shown adequate ability to detect hypomanic 
episodes in undergraduates (Eckblad and Chapman, 1986) and has predicted the onset of 
hypomania and mania in the same sample over an impressive thirteen-year follow-up (Kwapil et 
al., 2000). Across studies, persons with high HPS scores have demonstrated higher rates of 
mania and hypomania than those with low scores, as well as similarities to those with bipolar I 
disorder ( [Bentall and Thompson, 1990], [Johnson et al., 2005] and [Meyer and Johnson, 
2003]). The HPS has good reliability, with a Cronbach's alpha of .87 and a test–retest reliability 
of .81 over a fifteen-week period (Eckblad and Chapman, 1986). 
 
Reference standard (undergraduate sample): Schedule for Affective Disorders and 
Schizophrenia, Lifetime Version (SADS-L). The SADS-L (Endicott and Spitzer, 1978) was 
designed to assess Axis I diagnoses. The reliability and validity of the SADS-L has been 
established across 21 studies (Rogers et al., 2003). The SADS-L has good to excellent reliability 
for both symptoms and diagnoses, including reliability for manic episodes ( [Andreasen et al., 
1981], [Coryell et al., 1995] and [Rice et al., 1986]). 
 
Reference standard (clinic/community sample): Structured Clinical Interview for the DSM-IV 
(SCID). The SCID (First and Gibbon, 2004) is a semi-structured interview designed specifically 
to yield diagnoses based on DSM-IV criteria. This study involved administration of the mood 
and psychosis modules, allowing diagnoses of bipolar I and II disorders. It was also possible to 
obtain a diagnosis of bipolar NOS based on recurrent hypomania without any history of a major 
depressive episode, in line with DSM criteria (APA, 2000). The SCID was administered by 
graduate students who had completed detailed training in the SCID (involving written materials, 
didactic lectures, role plays, and reviews of interviews). SCID interviewers were blind to other 
study measures. Administration of the SCID was audio recorded, allowing reliability to be 
established under the direction of Sheri L. Johnson, PhD. Interviewers met weekly to review 
audiotapes and difficult diagnostic decisions. Interrater reliability for the diagnosis of bipolar 
was acceptable (κ = .84; Williams et al., 1992). 
Procedure. Participants from each sample completed the HPS. As described, HPS scores had 
been used to select participants for the undergraduate sample. All participants in both samples 
then completed the reference standard SADS-L or SCID. More details on the procedures for the 
undergraduate sample can be found in Eckblad and Chapman (1986). 
 
Results 
Table 1 contains tetrachoric correlations (used for dichotomous variables) between individual 
HPS items and a bipolar disorder diagnosis from both the undergraduate sample and the 
clinic/community sample. Preliminary analyses were conducted to investigate the ability of the 
full HPS to detect bipolar disorder in both subsamples. The HPS correlated strongly with a 
bipolar diagnosis in both the undergraduate sample (r = .41, p < .001) and the clinic/community 
sample (r = .56, p < .001). 
 
Table 1: Tetrachoric correlations between individual HPS items and bipolar disorder diagnosis 
in the undergraduate and mood clinic samples from Study 1. 
Hypomanic Personality Scale items—
Study 1 
Correlation w/ initial bipolar 
(undergraduate sample) 
Correlation w/ BP I 
diagnosis (mood clinic 
sample) 
 1. I consider myself to be pretty much an average kind of 
person. 
.29 .08  
2. It would make me nervous to play the clown in front 
of other people. 
.20 −.01  
3. I am frequently so “hyper” that my friends kiddingly 
ask me what drug I'm taking. 
.18 .38  
4. I think I would make a good nightclub comedian. .13 .22  
5. Sometimes ideas and insights come to me so fast that I 
cannot express them all. 
.14 .13  
6. When with groups of people, I usually prefer to let 
someone else be the center of attention. 
.25 .03  
7. In unfamiliar surroundings, I am often so assertive 
and sociable that I surprise myself. 
.25 .13  
8. There are often times when I am so restless that it is 
impossible for me to sit still. 
.12 .47  
9. Many people consider me to be amusing but kind of 
eccentric. 
.19 .24  
10. When I feel an emotion, I usually feel it with 
extreme intensity. 
.16 .38  
11. I am frequently in such high spirits that I can't 
concentrate on any one thing for too long. 
.29 .38 * 
12. I sometimes have felt that nothing can happen to me 
until I do what I am meant to do in life. 
.06 .19  
13. People often come to me when they need a clever 
idea. 
.30 −.10  
14. I am no more self-aware than the majority of people. .26 .19  
15. I often feel excited and happy for no apparent reason. .26 .14  
16. I can't imagine that anyone would ever write a book 
about my life. 
.31 .04  
17. I am usually in an average sort of mood, not too high 
and not too low. 
.41 .41 * 
18. I often have moods where I feel so energetic and 
optimistic that I feel I could outperform almost 
anyone at anything. 
.19 .22  
19. I have such a wide range of interests that I often 
don't know what to do next. 
.38 .26 * 
20. There have often been times when I had such an 
excess of energy that I felt little need to sleep at 
night. 
.26 .47 * 
21. My moods do not seem to fluctuate any more than 
most people's do. 
.34 .48 * 
22. I very frequently get into moods where I wish I could 
be everywhere and do everything at once. 
.31 .33 * 
23. I expect that someday I will succeed in several .23 .04  
different professions. 
24. When I feel very excited and happy, I almost always 
know the reason why. 
.19 .36  
25. When I go to a gathering where I don't know anyone, 
it usually takes me a while to feel comfortable. 
.25 −.05  
26. I think I would make a good actor, because I can 
play many roles convincingly. 
.31 .08  
27. I like to have others think of me as a normal kind of 
person. 
.33 .20  
28. I frequently write down the thoughts and insights 
that come to me when I am thinking especially 
creatively. 
.20 .17  
29. I have often persuaded groups of friends to do 
something really adventurous or crazy. 
.20 .08  
30. I would really enjoy being a politician and hitting the 
campaign trail. 
.05 .15  
31. I can usually slow myself down when I want to. .13 .42  
32. I am considered to be kind of a “hyper” person. .25 .37 * 
33. I often get so happy and energetic that I am almost 
giddy. 
.31 .40 * 
34. There are so many fields I could succeed in that it 
seems a shame to have to pick one. 
.27 .22  
35. I often get into moods where I feel like many of the 
rules of life don't apply to me. 
.32 .39 * 
36. I find it easy to get others to become sexually 
interested in me. 
.16 .09  
37. I seem to be a person whose mood goes up and down 
easily. 
.10 .43  
38. I frequently find that my thoughts are racing. .33 .38 * 
39. I am so good at controlling others that it sometimes 
scares me. 
.18 .24  
40. At social gatherings, I am usually the “life of the 
party”. 
.13 .11  
41. I do most of my best work during brief periods of 
intense inspiration. 
.08 .09  
42. I seem to have an uncommon ability to persuade and 
inspire others. 
.26 .12  
43. I have often been so excited about an involving 
project that I didn't care about eating or sleeping. 
.20 .30  
44. I frequently get into moods where I feel very 
speeded-up and irritable. 
.15 .54  
45. I have often felt happy and irritable at the same time. .26 .45 * 
46. I often get into excited moods where it's almost 
impossible for me to stop talking. 
.29 .46 * 
47. I would rather be an ordinary success in life than a 
spectacular failure. 
.17 .04  
48. A hundred years after I'm dead, my achievements 
will probably have been forgotten. 
.08 −.12  
* Asterisks indicate items correlating strongly with bipolar diagnosis in both samples. 
 
A subset of twelve items is marked by asterisks in the table. These items correlated relatively 
strongly with a bipolar disorder diagnosis in both samples (r ≥ .25). Two are reverse-coded (item 
17, “I usually tend to be in an average sort of mood, not too high and not too low”; and item 21, 
“My moods do not seem to fluctuate more than most people's do”), making them inappropriate 
for a simply-worded poster. 
 
To keep the scale brief, only the six items that had the highest average correlation across both 
samples were retained. These six items appear to have adequate content validity, tapping 
constructs associated with mania such as high energy, little need for sleep, happy and/or irritable 
mood, racing thoughts, talkativeness, and a disregard for rules. This six-item version (hereafter 
the HPS-6; see Table 2) correlated strongly in the undergraduate sample with the full-length HPS 
(r = .83, p < .001). The HPS-6 also correlated as robustly as did the full HPS did with a history 
of at least one manic episode (r = .43, p < .001). This pattern emerged in the clinic/community 
sample as well, with the HPS-6 correlating strongly with the full-length HPS (r = .81, p < .001) 
and with manic history (r = .63, p < .001). Alpha reliability for the full HPS was .93, as 
compared to .79 for the HPS-6. This difference can be accounted for by the relative length of the 
two scales according to the Spearman Brown prophecy equation (Stanley, 1971). 
 
Table 2: The HPS-6. 
1) There have often been times when I had such an excess of energy that I felt little need to sleep at night. 
2) I often get so happy and energetic that I am almost giddy. 
3) I often get into moods where I feel like many of the rules of life don't apply to me. 
4) I frequently find that my thoughts are racing. 
5) I have often felt happy and irritable at the same time. 
6) I often get into excited moods where it's almost impossible for me to stop talking. 
 
Further analyses suggested, however, that the cutoff required to achieve a positive screen would 
likely differ in the two populations. Table 3 contains sensitivity, specificity, and positive and 
negative predictive values for the HPS-6 and the full HPS at various cutoffs in each of the 
subsamples. Sensitivity and specificity in the undergraduate sample should be interpreted with 
caution, as stratified sampling biases these statistics. 
 
Table 3: Sensitivity, specificity, and positive and negative predictive values for the HPS and 
HPS-6, Study 1. 
 Sensitivity Specificity Positive predictive value (PPV) 
Negative predictive 
value (NPV) 
Full HPS (48 items)     
Clinic/community sample—cutoff of 25/48 
items 
.70* .88* .77 .83 
HPS-6     
Undergraduate sample—cutoff of all six 
items 
.88* .81* .56 .96 
Clinic/community sample—cutoff of 3/6 
items 
.89 .73 .67 .92 
* Asterisks indicate statistics that are biased due to stratified sampling. 
 
Discussion 
In Study 1 we set out to develop a briefer version of the HPS to screen for bipolar disorder. A 
small subset of items appeared to perform well in two different contexts: an undergraduate 
sample and a clinic/community sample. The HPS-6 worked as well as or better than the full HPS 
in detecting bipolar disorder in these samples. This is not surprising, as the items of the HPS-6 
were chosen specifically because they were among the best-performing items in the samples 
themselves. Cutoffs of three items endorsed in the mood clinic or six items endorsed in the 
undergraduate samples resulted in good sensitivity (.88 or higher) and modest specificity (.73 or 
higher) in both samples. Given Zimmerman and Mattia's (2001) argument that a measure should 
maximize sensitivity to be used as a screening tool, it would seem that cutoffs of three out of six 
(clinic/community) or all six (undergraduate) items represent the best threshold to screen for 
bipolar disorder in these settings. This discrepancy in cutoffs may reflect the different 
psychometric properties required in predominantly clinical versus predominantly non-clinical 
samples (for another example of differential cutoffs, see Langbehn et al., 1999 and Trull and 
Amdur, 2001). 
 
Several limitations should be acknowledged in interpreting these results. First, the primary 
outcome—presence of bipolar disorder—was assessed differently in the two subsamples. This 
makes comparisons in psychometric properties across samples difficult, but also provides a more 
robust test of the generalizability of results. Second, the two subsamples (labeled as 
undergraduate and clinic/community) were collected many years apart, and had significantly 
different mean ages. It is therefore possible that the requirement for different cutoffs may be due 
to age or cohort effects, rather than the settings from which the subsamples were drawn. Third, 
our statistical analyses relied primarily on simple correlations and cross-tabulations of HPS 
scores and bipolar history. Given the sheer number of correlations investigated (each of 48 items 
in two samples), it is possible that some of the apparently strong items achieved that strength 
across samples merely by chance. This highlights the need for replicating findings, as described 
next. 
 
Despite these limitations, the results from Study 1 suggest that a small subset of HPS items may 
screen for bipolar disorder more efficiently than the full 48-item HPS. Study 2 tested the 
application of these items in a real-world setting. 
 
STUDY 2 
The goal of Study 2 was to determine whether advertising featuring items derived from Study 1 
could be used to recruit research participants with bipolar disorder. Few studies have investigated 
the usefulness of self-report scales in the general population. What little research exists suggests 
that self-report screens are likely insensitive to bipolar disorder in the community (Hirschfeld et 
al., 2003). 
 
Methods 
All procedures for this study were approved by the University of Miami Institutional Review 
Board. The study was conducted between July and September of 2007. 
 
Participants. The sample included 100 people who responded to an advertisement posted on the 
Metrorail mass transit system in Miami-Dade County. The sample was 28% female, and the 
average age was 37.24 ± 11.99 years; total age range was from 18 to 59 years. The sample was 
racially heterogeneous, with 40% describing themselves as Caucasian, 40% as African-
American, and 20% as of other or mixed race. In addition to endorsing one of the racial 
categories described above, 41% of the sample also described themselves as Hispanic or 
Latino/a. 
 
Measures 
Reference standard: Structured Clinical Interview for the DSM-IV (SCID). The SCID (First and 
Gibbon, 2004) was administered over the telephone to those who called to express interest in the 
study. Modules were included for past and present depression, mania, and hypomania, allowing 
diagnosis of bipolar I or II disorder. We did not administer the cyclothymia module over the 
telephone, given concerns about the low reliability of milder forms of the bipolar spectrum 
(Isometsä et al., 2003). The psychosis module was administered, allowing for the diagnosis of 
schizoaffective disorder. The SCID has adequate reliability when administered by telephone 
(Cacciola et al., 1999). A small subset of participants also completed the same SCID modules in 
person (see Section 3.2). 
 
Procedure. An advertisement featuring the HPS-6 (developed in Study 1) was posted in 176 rail 
cars of the Miami-Dade County Metrorail system in the summer of 2007. It contained the items 
of the HPS-6, along with a heading asking “Does this describe you?” and an indication that 
persons endorsing three or more items could call to be screened for a separate study paying $25 
per hour. 
 
Participants who called to express interest in the study were read a brief script describing the 
research. Trained graduate students or research assistants asked basic demographic questions, 
and graduate students with substantial training on the SCID administered the modules described 
above over the telephone. Participants who appeared to meet criteria for bipolar I disorder based 
on the telephone interview and who also met other study criteria (i.e. did not have any medical 
rule-outs or current substance abuse) were invited to the University of Miami to take part in a 
larger study that included in-person administration of the same SCID modules. 
 
Results 
Eighty-four of the 100 respondents completed the SCID interview over the telephone. The 
remaining sixteen did not complete the telephone SCID for a variety of reasons, the most 
common of which were not speaking English or being unwilling to spend time answering 
questions over the telephone. Of the 84 people who completed the SCID, 41(49%) appeared to 
have no significant bipolar symptoms, 17 (20%) had bipolar I disorder, 12 (14%) had bipolar II 
disorder, four (5%) had substance-induced mania, three (4%) had schizoaffective disorder, and 
one (1%) had bipolar disorder NOS based on a history of recurrent hypomania without a history 
of depression. The remaining six participants (7%) reported a history of at least one hypomanic 
episode without a history of depression. 
 
Eight participants with a tentative diagnosis of bipolar I disorder without a history of brain 
trauma, neurological disorder, or current substance abuse based on the telephone SCID were 
invited to complete an in-person SCID. Five had their diagnosis of bipolar I disorder confirmed, 
one had the diagnosis downgraded to bipolar II disorder, and two did not appear to have a bipolar 
spectrum disorder. Of the last two participants, one reported a history of hypomania without 
depression and one reported a history of an impulse control disorder that did not appear to 
qualify as a bipolar disorder. 
 
Discussion 
Results from Study 2 suggest that a brief (six-item) screener can be used to recruit participants 
from the community for a study on bipolar disorder. If one defines the bipolar spectrum as 
consisting solely of bipolar I, bipolar II, and bipolar NOS disorders, then one-third (28/84) of 
those who called in response to the ad appeared to be on the bipolar spectrum according to a 
telephone-based SCID. It may be argued, however, that a useful screening tool for bipolar 
disorder (focused on episodes of mania/hypomania without reference to drugs, psychosis, or 
depression) would also be expected to identify those with hypomania, schizoaffective disorder, 
or substance-induced mania. Viewed in this light, 50% of those who called in response to the ad 
might represent “successes” on the part of the HPS-6. That is, fully half of participants reported 
at least one manic or hypomanic episode over the phone. In addition, it is unclear whether the 
remaining participants truly represent “false alarms” on the part of the HPS-6. It is possible that 
some or all of these participants had subclinical symptoms representing some type of 
vulnerability to bipolar disorder. 
 
Some limitations should be kept in mind when considering these results. First, the design of 
Study 2 did not allow us to consider different thresholds; it remains possible that a higher 
threshold would have minimized false positive screens. A second limitation was that the HPS-6 
was not readministered when participants called to express interest in the study. It is therefore 
possible that some participants actually endorsed fewer than three items on the advertisement, 
but called anyway due to misunderstanding of the wording, a desire to take part in paid studies 
even if they did not meet the exact eligibility criteria, etc. That we did not administer SCID 
modules for cyclothymia is another limitation, leaving open the possibility that some of our 
apparently non-bipolar participants would have met criteria for a milder form of bipolar 
spectrum disorder. A final limitation is that only those who appeared to have a bipolar I 
diagnosis on the telephone, and did not report any other study rule-outs, were invited to complete 
an in-person SCID. Unfortunately, bringing in more participants for a face-to-face SCID was not 
feasible. Past studies have found telephone-based diagnostic assessments to be reasonably 
reliable (e.g. Cacciola et al., 1999), but even so, results from Study 2 should be considered 
exploratory. 
 
Taken together, the results from Study 1 and Study 2 paint something of a mixed picture 
regarding bipolar disorder screening. The HPS and HPS-6 had relatively strong correlations with 
bipolar diagnosis in Study 1. In Study 2, fully half of those who responded to an ad featuring the 
HPS-6 reported a history of at least one manic or hypomanic episode on a telephone-based 
SCID. Although the HPS-6 thus appears to be a helpful tool, its psychometric properties for 
detecting bipolar disorder leave room for improvement, in that about half of persons with high 
scores did not appear to meet criteria for any bipolar spectrum disorder. In Study 3 we compared 
the utility of this brief scale versus two alternative scales as screeners for bipolar disorder 
diagnoses. 
 
STUDY 3 
The first two studies focused on the usefulness of the HPS in detecting bipolar disorder. Few 
studies have directly compared the sensitivity and specificity of different self-report screening 
tools for bipolar disorder diagnoses. In one study, Youngstrom et al. (2004) found that 
adolescents with bipolar disorder scored .7 standard deviations higher on the GBI and the Youth 
Self-Report Form (Achenbach, 1991) than their non-bipolar counterparts. Sensitivity and 
specificity were not reported in that study. We are unaware of any studies, in fact, that have 
compared sensitivity and specificity indices in a young adult sample. 
 
The goal of Study 3 was to assess whether any of three screeners could be used to detect bipolar 
disorder among undergraduates. In Study 3, participants completed the HPS, the MDQ, and the 
GBI-15 (the latter two of which are described in more detail in 4.1.2.2 and 4.1.2.3). Scores on 
those measures were used as potential predictors of SCID diagnoses of bipolar disorder. 
 
Methods 
All procedures for this study were approved by the University of Miami Institutional Review 
Board. This study was conducted between the fall of 2006 and the winter of 2007. 
 
Participants. Participants were University of Miami undergraduates, who took part in the study 
in partial fulfillment of a course requirement. About 1200 students completed the three self-
report screeners during group testing sessions on the first few days of the semester (the 
“screening sample”). Demographic information for the screening sample is limited, but most 
students were either eighteen or nineteen years old, and approximately 62% were female. 
Students who were selected using the stratified random sampling design (described in Section 
4.1.3) were contacted via email and invited to participate in the study; those who chose to 
participate (N = 103) were enrolled. This final sample was 62% female, and the average age was 
18.62 ± .83 years (range from 18 to 22 years). Six percent of participants were Asian-American, 
9% were African-American, 17% were Hispanic/Latino, 60% were Caucasian, and 9% were of 
another or mixed ethnicity. 
 
Measures. The primary measures for this study were three self-report screeners for bipolar 
disorder. For each of the screeners, cutoffs were chosen to create balanced sampling: that is, 
those who scored above a z-score of about 1.55 were given a positive screen. This cutoff aligns 
closely with those used in similar studies (Eckblad and Chapman, 1986). The Structured Clinical 
Interview for the DSM-IV (First and Gibbon, 2004) served as the reference standard. 
 
Hypomanic Personality Scale (HPS). Details on the HPS (Eckblad and Chapman, 1986) are 
described in Study 1. For Study 3, endorsing 32 or more items on the full HPS resulted in a 
positive screen. Parallel analyses were also conducted using the HPS-6, described earlier. 
 
Mood Disorder Questionnaire (MDQ). The MDQ (Hirschfeld et al., 2005 and Hirschfeld et al., 
2003) is a self-report inventory designed to screen for lifetime history of a manic or hypomanic 
episode based on thirteen yes/no questions. The questions were derived from the DSM-IV 
criteria for bipolar disorder as well as clinical experience. Additional questions focus on whether 
the symptoms reported occurred at the same time (the “simultaneity” criterion) and caused at 
least moderate functional impairment (the “severity” criterion). In its original validation studies, 
achieving a positive screen required that a participant answer at least seven out of the 13 yes/no 
questions as “yes,” and endorse both the simultaneity and severity criteria (Hirschfeld et al., 
2005 and Hirschfeld et al., 2003). The MDQ has good internal consistency (Hirschfeld et al., 
2000), and has been used in advertisements meant to promote awareness of bipolar disorder 
(AstraZeneca, 2006). In an initial study, the MDQ demonstrated a sensitivity of .73 and a 
specificity of .90 for detecting bipolar spectrum diagnoses (bipolar I, bipolar II, and bipolar 
NOS) in a mood disorders clinic (Hirschfeld et al., 2000). Subsequent studies, however, have 
found limited sensitivity to bipolar II disorder in an outpatient sample (Miller et al., 2004) and 
low sensitivity to bipolar disorders overall in the general population (Hirschfeld et al., 2003). In 
our sample the severity and simultaneity criteria were retained, but the cutoff for a positive 
screen was raised to 11 out of the 13 initial items of the MDQ due to the high rate of 
endorsement for many of the items (e.g. four of the thirteen items had an endorsement rate of at 
least 75%, and nearly 75% of the screening sample endorsed seven or more of the initial items). 
 
General Behavior Inventory—15-item version (GBI-15). The GBI (Depue et al., 1989 and Depue 
et al., 1981) was designed to identify lifetime bipolar affective disorders. In its complete 73-item 
form, the GBI has been validated in both undergraduate (Depue et al., 1989) and outpatient 
(Klein et al., 1989) samples. Items are rated on a one to four scale ranging from “never or hardly 
ever” to “very often or almost constantly.” This study used the 15-item version (the GBI-15; 
Meyer and Johnson, 2003). The GBI-15 contains three subscales: depression (six items), 
hypomanic (five items), and biphasic (four items referring to rapid mood fluctuations). In the 
original development study, each of these subscales correlated highly with its respective subscale 
in the full-length GBI (r > .84 in each case), and demonstrated good internal consistency 
(Cronbach's alpha >.70 in each case). Classification efficiency (using the full-length GBI as a 
gold standard) exceeded .92. The current study used only the latter two subscales in assigning a 
positive screen: endorsing four or more of the nine hypomanic/biphasic items represented a 
positive screen. 
 
Reference standard: Structured Clinical Interview for the DSM-IV (SCID). As stated earlier, the 
reference standard for this study was the SCID, administered by highly trained graduate students. 
Once again, the mood, psychosis, and substance abuse modules were administered. In addition, a 
custom cyclothymia module (based on the DSM cyclothymia criteria and interview probes 
developed by Alloy's group; see Shen et al., 2008) was administered to capture this milder form 
of the bipolar spectrum. That is, a diagnosis of cyclothymia was given if the participant endorsed 
two years (or one year if under eighteen years old) of numerous high and low periods lasting 
days at a time. These periods were required to involve at least two manic (for high) and two 
depressed (for low) symptoms, and participants could not receive a cyclothymia diagnosis if they 
endorsed any two-month period that was free from such high and/or low periods. Ten percent of 
tapes were reviewed for reliability in the mania and hypomania modules. Disagreement arose 
only regarding one diagnosis for one participant, such that the intraclass correlation coefficient 
for diagnosis was .79 for past hypomania and absolute agreement (1.00) for diagnoses of current 
hypomania and current and past mania. 
 
Procedure. The screening sample (n = 1204) completed the HPS, MDQ, and GBI-15 during the 
first week of class. Participants with high scores on the screening tools were oversampled. 
Specifically, all participants who screened positive on the HPS, MDQ, and/or the GBI-15 were 
invited to participate in an additional two-hour session as part of the final sample. In contrast, 
only a randomly selected 7% of those with low scores on at least one screener were invited to be 
a part of the final sample. Forty-eight percent of the high scorers participated in the final study, 
while 31% of the low scorers who were invited to take part in the study did so. 
 
The final session involved completion of an informed consent form, the SCID, and other 
measures unrelated to the current report. The final sample included 23 persons with low scores 
on all three measures, and 80 persons with high scores on at least one screener. (Due to overlap 
in some high and low scores across measures, high scorers numbered 32 for the HPS, 35 for the 
MDQ, and 35 for the GBI-15. It was possible for participants to be enrolled as a “high-scorer” on 
one measure but a “low-scorer” on the others, resulting in control groups that also differed 
slightly in size across the three screening tools). See Table 4 for means and standard deviations 
for each of the screening tools. After this session, participants were debriefed and referrals were 
provided as needed. 
 
Analysis plan. The primary outcome for these analyses was the presence of a bipolar spectrum 
diagnosis (bipolar I disorder, bipolar II disorder, cyclothymia, or bipolar NOS). Sensitivity and 
specificity, reported earlier for Study 1, are biased by stratified sampling designs such as the one 
used here (Kraemer, 1992). Several existing methodologies can adjust for different types of 
stratification schemes (Choi, 1992, Sukhatme and Beam, 1994 and Weinstein et al., 1989). Of 
these methods, that described by Choi (1992) is most useful for easily deriving sensitivity and 
specificity in the context of stratification. 
 
This study also used positive and negative predictive values, which are less biased by stratified 
sampling. Positive predictive value (PPV) is defined as the proportion of participants who screen 
positive on a particular measure who meet the relevant diagnostic criteria. Negative predictive 
value (NPV), in contrast, is defined as the proportion of participants who screen negative on a 
particular measure who fail to meet diagnostic criteria. 
 
Results 
Results are presented separately below for the screening sample (N = 1204) and the final sample 
(n = 103). 
 
Screening sample. Table 4 contains information regarding the mean, SD, and scale reliability 
for each of the self-report screening tools. The Spearman Brown Prophecy Formula (Stanley, 
1971) estimates expected reliability when scales are shortened; in this sample the HPS-6 
appeared less reliable (alpha = .58) than would be expected (expected alpha = .70) given the 
reliability of the full HPS (alpha = .85). 
 
Table 4: Mean, standard deviation, and reliability for screeners across different samples, Study 3. 
 Sample N Mean SD Reliability 
Full HPS Screening sample 1174 19.43 8.01 .85 
Full HPS Screen-positive group 32 35.31 3.18 * 
Full HPS Screen-negative group 25 18.18 6.11 * 
HPS-6 Screening sample 1171 2.22 1.62 .58 
MDQ Screening sample 1196 8.19 3.04 .78 
MDQ Screen-positive group 35 11.71 .79 * 
MDQ Screen-negative group 24 8.02 3.27 * 
GBI-15 Screening sample 1199 .94 1.58 .75 
GBI-15 Screen-positive group 35 5.20 1.47 * 
GBI-15 Screen-negative group 24 .63 1.01 * 
GBI-15—cyclothymic subscale Screening sample 1197 .55 1.00 .70 
GBI-15—hyperthymic subscale Screening sample 1195 .39 .82 .59 
*Due to stratified sampling, reliability statistics for these samples would be severely biased, and therefore are not included. 
 
Final sample. Stratified random sampling resulted in a final sample size of 103. Table 4 contains 
information regarding mean, standard deviation, and reliability for each of the screening tools 
among both high and low scorers. Eighteen of the 103 participants met diagnostic criteria for a 
bipolar spectrum disorder, including seven with bipolar I disorder, six with bipolar II disorder, 
two with cyclothymia, and three with bipolar disorder NOS. This apparently high prevalence is 
not surprising, given this study's oversampling of participants with high scores on the self-report 
screeners. 
 
Preliminary analyses tested whether demographic characteristics were related to scores on any of 
the three screeners in the final sample. Independent samples t-tests (for gender), one-way 
ANOVAs (for ethnicity), and correlations (for age) revealed no significant relationships with 
screening scores (all t < 1.5, F < 1.2, r < .07, n.s.; all Cohen's d < .3 for t-tests), with one 
exception: age was significantly correlated with the GBI-15 (r = .25, p = .03). This result may be 
an artifact of the number of comparisons undertaken to identify confounds.2 
 
Preliminary analyses also examined whether there was bias in which participants accepted 
invitations to take part in the second part of the study. Independent samples t-tests suggested that 
those who participated in the final sample did not differ significantly on HPS, MDQ, or GBI-15 
scores (all ts < .6, n.s.) compared to those who declined invitations to be in the final sample. 
 
Diagnostic efficiency statistics 
Correlations among the self-report screeners (including the HPS-6) as well as their correlations 
with a bipolar spectrum diagnosis are presented in Table 5. Correlations among the screeners 
were generally in the small to moderate range. Point-biserial correlations with bipolar spectrum 
diagnosis were generally low for all of the screeners, ranging between .09 and .19 (all n.s.). 
 
Table 5: Correlations among total scores for screeners and bipolar spectrum diagnosis, Study 3. 
 HPS MDQ GBI-15 HPS-6 Bipolar spectrum diagnosis 
HPS – .37** .42** .69** .14 
MDQ – – .31** .45** .10 
GBI-15 – – – .43** .19 
HPS-6 – – – – .09 
Note. Correlations between self-report screeners are based on the entire screened sample (N = 1204). Correlations involving bipolar spectrum 
diagnosis are drawn from the final sample (N = 103). 
**p < .01. 
 
Table 6 includes positive and negative predictive values, as well as sensitivity and specificity 
adjusted to account for stratified sampling (Kraemer, 1992). Each scale demonstrated high NPV 
(.88 to .92) and adjusted specificity values (.93 to .95). That is, most persons who obtained low 
scores on the screeners did not meet criteria for a bipolar spectrum diagnosis. The HPS and 
MDQ had relatively low PPV (.19 to .20) and adjusted sensitivity values (.09 to .11). The GBI-
15 had somewhat higher, yet still modest, PPV and sensitivity. On the whole, only 20–30% of 
persons with a high score on a screener met diagnostic criteria for a bipolar spectrum disorder. 
 
Table 6: Sensitivity, specificity, and positive and negative predictive values for each screener, 
Study 3. 
Screener Cutoff PPV NPV Sensitivity (adjusted) Specificity (adjusted) 
HPS 32 items .19 (6/32) .88 (22/25) .09 .95 
MDQ 11/13 items plus simultaneity/severity .20 (7/35) .88 (21/24) .11 .93 
GBI-15 4 items .31 (11/35) .92 (22/24) .26 .93 
Note: Only 7 participants achieved a positive screen on the HPS-6 using a cutoff of all six items (based on Study 1), and so it has not been 
included in the table. 
 
The analyses above used cutoffs that differed from those reported in the literature. Parallel 
analyses were conducted using previously recommended cutoffs, which were generally less 
stringent than those used above. These analyses were limited, as our stratification scheme had 
relied on the higher thresholds. Nonetheless, our limited analyses suggested that adjusting cutoffs 
did not yield marked improvements in sensitivity or specificity. 
 
Discussion 
The goal of Study 3 was to investigate the psychometric properties of three brief self-report 
screeners for detecting bipolar disorder among undergraduates. Sensitivity estimates for all three 
scales were low. That is, sensitivity to a bipolar spectrum diagnosis was less than .30 for each 
screener, suggesting that each would miss more than 70% of bipolar spectrum diagnoses in 
similar college populations (and more than 85% in the cases of the HPS and MDQ). The adjusted 
NPV for the screeners in this study was high (above .93 in all three cases). That is, a participant 
scoring below the cutoff on a screener is unlikely to have a bipolar spectrum condition. These 
two statements—that the screeners would miss the majority of bipolar diagnoses, but that any 
given individual with a low screener score is unlikely to have bipolar disorder—may seem 
contradictory, but can be reconciled by the low base rate of bipolar disorder in typical 
undergraduate populations. These data illustrate how difficult it can be to detect a disorder with a 
low prevalence (e.g. suicidality, see Pokorny, 1983): even if specificity is relatively high, the 
number of false positives will quickly overwhelm the number of true positives. 
 
The specificity for each scale was above .90, meaning that over 90% of those without bipolar 
disorder would be expected to screen negative using these tools. This number is generally 
consistent with previous findings on bipolar screening tools (Hirschfeld et al., 2005, Depue et al., 
1981 and Klein et al., 1989). PPV for the HPS and MDQ generally fell between .15 and .20, 
suggesting that only one out of every five to six college students scoring above the cutoff on 
these measures would be expected to have a bipolar spectrum condition. The GBI-15 performed 
better, with about one in three high scorers achieving a bipolar spectrum diagnosis according to 
the SCID. Previous studies suggest that less than one in twenty undergraduates in an unscreened 
population might be expected to have a bipolar spectrum disorder (Lewinsohn et al., 1995). 
Accordingly, this PPV for the GBI-15 may be seen as encouraging, but also leaves room for 
improvement. 
 
In sum, low scores on one of these measures are a fairly good indicator that a person would not 
meet criteria for a bipolar spectrum disorder. High scores, though, are only a rough indicator of 
likelihood of diagnosis. One potential solution would be to use higher scores as indicators, but 
doing so would reduce sensitivity even further, leaving a larger proportion of bipolar spectrum 
diagnoses undetected. 
 
Overall, the screening tools in this study identified a large ratio of false positives to true 
positives, while also failing to identify a large proportion of bipolar spectrum diagnoses. Put 
another way, these tools label as bipolar many people who do not have a bipolar spectrum 
disorder, while simultaneously letting most of bipolar spectrum diagnoses slip through the 
cracks. This combination of a large number of false positives and low sensitivity to bipolar 
disorder is disheartening. 
 
Scale-specific issues. There are several possible explanations for these findings. Some of the 
issues are specific to a given scale. In reference to the MDQ, the low rates of diagnosis (20% of 
those with a high score) were especially striking, because we used a higher cutoff (11 out of 13 
items) for a positive screen than previous studies have used (7 items). One would expect that this 
would yield a sample at greater risk for a bipolar spectrum diagnosis than the traditional cut-off, 
but this was not the case. Many of the MDQ symptom items reference experiences that are quite 
common among college students (e.g., “have you ever had a time…when you were much more 
active or did many more things than usual?”). Most college students go through such times 
routinely for exams and other normative aspects of college life. Indeed, several items on the 
MDQ were endorsed by more than three quarters of the screening sample, suggesting that these 
items may be of limited usefulness in college students. 
 
The items on the MDQ that tap symptoms, however, may be only part of the problem. Previous 
research suggests that requiring that symptoms be rated as causing moderate impairment can 
impair the MDQ's diagnostic utility. This may be especially true for bipolar II disorder because 
by definition, hypomania (the defining characteristic of bipolar II disorder) is not characterized 
by significant impairment (APA, 2000). Therefore, both the symptom items and the severity 
criterion of the MDQ appear problematic. 
 
In reference to the HPS, about half of the items refer to fairly constant patterns rather than 
episodic periods of symptoms (e.g., “I am so good at controlling others that it sometimes scares 
me.” and “Many people consider me to be amusing but kind of eccentric.”), whereas the DSM 
emphasizes the episodic. It is also the case that many items do not directly assess DSM-IV 
symptoms of mania, and no items assess the duration of symptoms. The lack of content overlap 
with DSM criteria might have limited the accuracy of this scale in predicting DSM bipolar 
spectrum diagnoses. More broadly, a focus on episodes of abnormally elevated mood and 
behavior, versus a focus on consistent or enduring traits, is an important one to consider in 
bipolar screening tools. The MDQ focuses on episodes, while the HPS and GBI-15 contain a mix 
of episodic- and personality/temperament-related items; this difference may help explain the 
modest correlations between total scores for these scales. As such, the HPS and GBI-15 may be 
better seen as vulnerability markers for bipolar disorder rather than screening tools per se; the 
performance of the HPS in predicting bipolar diagnoses over a thirteen-year follow-up lends 
weight to this interpretation (Kwapil et al., 2000). 
 
The GBI-15 has other issues. Many of its items are grammatically complex (e.g., “Have you 
experienced periods of several days or more when, although you were feeling unusually happy 
and intensely energetic [clearly more than your usual self], you also were physically restless, 
unable to sit still and had to keep moving or jumping from one activity to another?”). This 
complexity presumably interferes with interpretability. On the other hand, the GBI-15 is the only 
scale of the three that specifically covers duration and frequency for each symptom assessed. 
This might explain the higher PPV estimates for this scale compared to the HPS or the MDQ. 
 
Comparisons with prior research. Across the scales, these findings compare unfavorably to 
many previous reports regarding these same scales (e.g. Eckblad and Chapman, 1986, Hirschfeld 
et al., 2005, Ghaemi et al., 1999 and Depue et al., 1981). Why might this be? One possibility 
concerns differences among samples. Our sample differs from those used in some of the original 
validation studies in two ways. First, we did not use an inpatient sample. Differentiating mania 
from other inpatient disorders, such as schizophrenia, may be less challenging than 
differentiating mania from absence of disorder. Indeed, at least one other study has obtained 
similarly low sensitivity and specificity estimates for self-report screeners in the general 
population (Hirschfeld et al., 2003). 
 
Second, this study focused on a young adult population. This sample is younger than those of 
most studies on adults, but older than studies of children or adolescents. In a recent meta-analysis 
focused on youth, Youngstrom et al. (2004) reported low sensitivity and specificity for self-
report scales among adolescents age 11–17. They found that parent report provided better 
diagnostic utility, suggesting that younger populations may be less accurate in reporting their 
bipolar symptoms. It is possible that our sample—with an average age of 18.62 years—similarly 
reflects such inaccuracy. Informant reports might have improved the validity of the screening 
tools. 
 
Concerns about the young adult sample may apply to our gold standard SCID as well. Beyond 
the issues of self-awareness of symptoms in a younger sample, age may also influence the rate of 
symptom expression. The median age of onset for bipolar disorder is estimated to be around age 
20–25 (American Psychiatric Association, 2000 and Kennedy et al., 2005). Thus some 
participants without a bipolar diagnosis at the time of the interview in the current study may 
develop episodes later. Indeed, Kwapil et al. (2000) found that the HPS predicted bipolar 
diagnoses at thirteen-year follow-up. 
 
Other aspects of this study should be kept in mind when interpreting these results. Despite 
administering scales to over 1200 persons and oversampling high scorers on the scales, only 
seven participants received a diagnosis of bipolar I disorder, with another eleven receiving 
diagnoses elsewhere on the bipolar spectrum. This represents a difficulty inherent to studying a 
rare disorder in a non-clinical population. For this reason, study results should be interpreted 
with caution. 
 
In summary, this study produced mixed results regarding the usefulness of the HPS, MDQ, and 
GBI-15 in detecting bipolar disorder among undergraduates. In terms of PPV, approximately one 
in three positive screens on the GBI-15 yielded a bipolar spectrum diagnosis. Despite this 
modestly encouraging result, none of the screeners showed an ability to successfully detect more 
than 30% of persons with a bipolar spectrum condition. To be useful in routine screening, a 
minimum sensitivity of .90 is recommended (Zimmerman and Mattia, 2001); thus none of these 
screening tools can be recommended for college populations. 
 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
This article presented results from three studies on the detection of bipolar disorder via brief self-
report scales. In Study 1, the HPS was administered to an undergraduate and a clinic/community 
sample. This revealed a small subset of HPS items that correlated particularly well with bipolar 
diagnosis across samples, allowing creation of the briefer HPS-6. In Study 1, the HPS-6 had 
good sensitivity and modest specificity in both samples, although different cutoffs were required 
across samples. 
 
In Study 2, the HPS-6 was used in an advertisement on the public transportation system in 
Miami to recruit participants with bipolar I disorder for a research study. On the SCID, half of 
the 84 callers who were interviewed reported a history of at least one manic or hypomanic 
episode. 
 
Study 3 used stratified sampling among undergraduates, and administered the full-length HPS as 
well as the MDQ and GBI-15. None of these scales showed adjusted sensitivity to a bipolar 
spectrum disorder higher than .30. Moreover, PPV for the three screening tools fell in the range 
of .15–.30. This latter result was roughly comparable to results from Study 2, in which one in 
three respondents had a bipolar spectrum disorder. Another potential explanation for the results 
of Study 3 is that many behaviors that might clearly reflect bipolarity in clinical settings (e.g. 
periods of intense activity with little sleep) may be normative in college populations. 
 
What do these results suggest for future refinements to screening tools? One thing to consider is 
the scope of the questions that each screener contains. Of the self-report screeners investigated in 
these studies, only the GBI-15 references severity, frequency, and duration within each question; 
this may explain its marginally superior performance in Study 3. There is a need for a scale that 
captures these dimensions, yet uses simpler wording. In addition, measures that tap temperament 
rather than episodes may be useful in detecting bipolar disorder; ideally, future studies will 
subject such measures to analyses of sensitivity and specificity (e.g. the TEMPS-A; Akiskal et 
al., 2005). In sum, the current findings suggest that there is much room for improvement when it 
comes to self-report screening tools for bipolar disorder. However, several promising avenues for 
improving such scales have yet to be fully explored. 
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